Personal insulin pumps in children and adolescents with type 1 diabetes mellitus;Ocena leczenia cukrzycy typu 1 u dzieci i młodzieży przy pomocy osobistych pomp insulinowych

Diabetologia Polska

Volumn 7, Issue 4, 2000, Pages 224-227

  Noczynska A ^a   Wasikowa R ^a  

^a Klin Endokrynol Wieku Rozwojowego   (Poland)

Author keywords

Children and adolescents; Optimalization of therapy; Therapy with personal pumps; Type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN LISPRO; ISOPHANE INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES CONTROL; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MALE; PATIENT SATISFACTION; SCHOOL CHILD; SELF MONITORING;

EID: 0034431948     PISSN: 12334723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Reduction in severe hypoglycemia with long-term continuous subcutaneous-insulin infusion in type 1 diabetes
2. A flexible option for adolescents with diabetes. Insulin pump therapy
3. Use of continuous subcutaneous insulin infusion in young adolescents with diabetes mellitus: A case study
4. Effect of patient-selected intensive insulin therapy on quality of life
5. Continuous subcutaneous insulin injection for self-care of young patients with insulin-dependent diabetes mellitus
6. Insulin pump therapy Situations and solutions. Lippincotts
7. Stability of insulin infusion system
8. A primer on the use of insulin pumps in adolescents
9. Risks and side effects of intensified insulin therapy
10. Individualized insulin therapy in children and adolescents with type 1 diabetes
11. Liberalized diet in patients with type 1 diabetes
12. Insulin pump therapy: Acceptable alternative to injection therapy
13. Insulin lispro: The ideal pump insulin for patients with severe hypoglycemic unawareness?
14. Cessation of insulin infusion at night-time during CSII-therapy: Comparison of regular human insulin and insulin lispro
15. Human insulin analogue {LYS(B28), PRO(B29)}: The ideal pump insulin?
16. Insulin-kinetic and dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp)
17. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and the treatment of acutely decompensated IDDM
18. Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria
19. Insulin pump treatment for recurrent ketoacidosis in adolescence
20. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial
21. Insulin replacement therapy in diabetic rats using an osmotic pump normalizes expression of enzymes key to hepatic carbohydrate metabolism
22. Contact Allergy to components of glue in insulin pump infusion sets
23. Allergic contact dermatitis from acrylates in insulin pump infusion sets